|Alma mater||Columbia University College of Physicians and Surgeons, Georgetown University|
|Interests|| • biological weapons|
Inglesby completed his internal medicine and infectious diseases training at Johns Hopkins University School of Medicine, where he also served as Assistant Chief of Service in 1996-97. Inglesby received his MD from Columbia University College of Physicians and Surgeons and his BA from Georgetown University.
Inglesby is director of the think-tank Center for Health Security, a part of the Johns Hopkins Bloomberg School of Public Health. He is an expert on public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats.
The center, partnering with the neo-conservative American Enterprise Institute, in early May 2020 published a “roadmap for reopening,” which spelled out conditions under which states should move toward loosening stay-at-home orders.
He was Chair of the Board of Scientific Counselors, Office of Public Health Preparedness and Response, US Centers for Disease Control and Prevention (CDC) from 2010-2019.
He was Chair of the National Advisory Council of the Robert Wood Johnson Foundation’s National Health Security Preparedness Index. He was a member of the CDC Director’s External Laboratory Safety Workgroup, which examined biosafety practices of the CDC, the National Institutes of Health (NIH), and the Food and Drug Administration (FDA) following high-profile laboratory incidents in federal agencies.
He was on the 2016 Working Group assessing US biosecurity on behalf of the President’s Council of Advisors on Science and Technology (PCAST). He has served on committees of the Defense Science Board, the National Academies of Sciences, and the Institute of Medicine, and in an advisory capacity to NIH, the Biomedical Advanced Research and Development Authority, the Department of Homeland Security, and the Defense Advanced Research Projects Agency.
Inglesby is also a Professor in the Department of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health, with a Joint Appointment in the Johns Hopkins School of Medicine.
Inglesby has authored or co-authored more than 140 publications, including peer-reviewed research, reports, and commentaries on issues related to health security, preparedness for epidemics, biological threats, and disasters.
In December 2014 with Marc Lipsitch, Thomas Inglesby published a Moratorium on Research Intended to Create Novel Potential Pandemic Pathogens that stated the "gain of function" research on viruses "poses extraordinary potential risks to the public."
He is Editor-in-Chief of the journal Health Security, which he helped establish in 2003. He was a principal editor of the JAMA book Bioterrorism: Guidelines for Medical and Public Health Management.
Events Participated in
|Atlantic Storm||14 January 2005||14 January 2005||New York|
|A scenario designed to mimic a summit of transatlantic leaders forced to respond to a bioterrorist attack. Recommended militarization, vaccination and stockpiling drugs. Held January 2005.|
|Event 201||18 October 2019||18 October 2019||New York|
|A Johns Hopkins Center for Health Security/World Economic Forum/Bill & Melinda Gates Foundation sponsored large scale simulation of a global coronavirus pandemic predicting an apocalyptic outcome. Held October 2019.|
|Operation Dark Winter||22 June 2001||23 June 2001||Washington DC|
Andrews Air Force Base
|An exercise where senior former officials would respond to a bioterrorist induced national security crisis. Uncannily predicted the 2001 anthrax attacks and other narratives. Held June 2001.|
|Document:All Roads Lead to Dark Winter||report||1 April 2020||Whitney Webb|